Bot Detector
Download FREE Sample Issue or Article
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Use of Domperidone as a Prokinetic and Antiemetic

Author(s):  Albright Lisa M

Issue:  Mar/Apr 2005 - Health and Wellness
View All Articles in Issue

Page(s):  120-125

Use of Domperidone as a Prokinetic and Antiemetic Page 1
Use of Domperidone as a Prokinetic and Antiemetic Page 2
Use of Domperidone as a Prokinetic and Antiemetic Page 3
Use of Domperidone as a Prokinetic and Antiemetic Page 4
Use of Domperidone as a Prokinetic and Antiemetic Page 5
Use of Domperidone as a Prokinetic and Antiemetic Page 6

Download in electronic PDF format for $75

Abstract:  Domperidone is a synthetic benzimidazole compound that acts as a dopamine D2 receptor antagonist. Its localization outside the blood-brain barrier and antiemetic properties have made it a useful adjunct in therapy for Parkinson’s disease. There has been renewed interest in antidopaminergic prokinetic agents since the withdrawal of cisapride, a 5-HT4 agonist, from the market. Domperidone also is as a prokinetic agent for treatment of upper gastrointestinal motility disorders. It continues to be an attractive alternative to metoclopramide because it has fewer neurological side effects. Patients receiving domperidone or other prokinetic agents for diabetic gastropathy or gastroparesis should also be managing diet, lifestyle, and other medications to optimize gastric motility.

Related Keywords: Lisa M. Albright, PhD, domperidone, gastrointestinal motility, dopamine D2 receptor, vomiting, Parkinson's disease, prokinetic, antiemetic, diabetic gastropathy, gastroparesis, diabetes, gastric emptying


Printer-Friendly Version

Related Articles from IJPC
(Click for Abstract / Details / Purchase)
Use of Domperidone as a Prokinetic and Antiemetic
Albright Lisa M
Mar/Apr 2005
Pg. 120-125

View Sample
Five Compounds for Treating Diabetes-Related Conditions
Meece Jerry
May/Jun 2003
Pg. 170-174

Domperidone 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Nov/Dec 2021
Pg. 500

Literature Review: The Dual Role of Domperidone in Gastroparesis and Lactation
Phan Ha
, DeReese Annie, Day A J, Carvalho Maria
May/Jun 2014
Pg. 203-207

Domperidone 5 mg/mL in Oral Mix
Allen Loyd V Jr
Jul/Aug 2019
Pg. 316

Compounding Prokinetic Medications for Companion Animals
Gaskins Jessica
Jul/Aug 2012
Pg. 276-286

Domperidone in Lactation: Use as a Galactagogue
Albright Lisa M
Sep/Oct 2004
Pg. 329-335

Domperidone 1-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2006
Pg. 61

Basics of Compounding for Raynaud's Disease
Glasnapp Andrew
Jul/Aug 2003
Pg. 288-291

The Treatment of Canine Atopic Disease
Davidson Gigi S
May/Jun 2002
Pg. 210-215

Profile of a Practice: Ward Drug Company Diabetic Shoppe and Prescription Compounding Center
Vail Jane
Jan/Feb 2003
Pg. 21-23

Complications of Diabetes
Key David M
Mar/Apr 2000
Pg. 88-90

Treating Canine Hepatic Disease
Davidson Gigi S
May/Jun 2003
Pg. 188-191

Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease
Glasnapp Andrew
, Schaefer Erin
Jul/Aug 2000
Pg. 276-279

Nausea and Vomiting in Hospice Patients
Boomsma Diane
Jul/Aug 2000
Pg. 250-251

Case Report: Wound Care of a Diabetic Foot Ulcer
Wynn Tom
Jul/Aug 2004
Pg. 265-267

The Clinical Pharmacist's Role in Compounding for the Diabetic Patient
Harshbarger Robert
, Harshbarger Diana
Mar/Apr 2000
Pg. 84-87

Metoclopramide 5-mg/mL Injection
Allen Loyd V Jr
May/Jun 2012
Pg. 243

Antiemetic Suppositories of the Gralla Type
Allen Loyd V Jr
Jan/Feb 1997
Pg. 28

Antiemetic Injection for Cancer Chemotherapy
Allen Loyd V Jr
May/Jun 1997
Pg. 175

Return to Top